Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Armata Pharmaceuticals (ARMP) Preferred Dividend Payments (2016)

Quarterly results put Preferred Dividend Payments at $133000.0 for Q2 2016, down 92.72% from a year ago — trailing twelve months through Dec 2016 was $1.9 million (down 81.92% YoY), and the annual figure for FY2016 was $1.9 million, down 81.92%.

Armata Pharmaceuticals has reported Preferred Dividend Payments over the past 4 years, most recently at $133000.0 for Q2 2016.

  • Preferred Dividend Payments reached $133000.0 in Q2 2016 per ARMP's latest filing, down from $1.7 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $7.2 million in Q3 2015 and bottomed at $103000.0 in Q2 2013.
  • Median Preferred Dividend Payments over the past 4 years was $323000.0 (2014), compared with a mean of $1.1 million.
  • The largest annual shift saw Preferred Dividend Payments soared 2117.65% in 2015 before it crashed 92.72% in 2016.
  • Over 4 years, Preferred Dividend Payments stood at $229000.0 in 2013, then skyrocketed by 44.1% to $330000.0 in 2014, then skyrocketed by 187.58% to $949000.0 in 2015, then plummeted by 85.99% to $133000.0 in 2016.
  • Business Quant data shows Preferred Dividend Payments for ARMP at $133000.0 in Q2 2016, $1.7 million in Q1 2016, and $949000.0 in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2016 133,000.00